Literature DB >> 22868445

Time required for navigated macular laser photocoagulation treatment with the Navilas.

Michael D Ober1, Marcus Kernt, Marco A Cortes, Igor Kozak.   

Abstract

BACKGROUND: Navilas laser is a novel technology combining photocoagulation with imaging, including fluorescein angiographic (FA) images which are annotated and aligned to a live fundus view. We determine the time necessary for planning and treatment of macular edema utilizing the Navilas.
METHODS: The screen recordings during treatments were retrospectively analyzed for treatment type, number of laser shots, the duration of planning (measured from the time the planning image was selected to time of marking the last planned treatment spot), and total time of laser application.
RESULTS: A total of 93 treatments (30 grid, 30 focal and 33 combined treatments) by four physicians from three sites were included. An average of 125 spots were applied to each eye. The total time spent for each focal treatment - including the planning was 7 min 47 s (±3 min and 32 s).
CONCLUSIONS: Navilas is a novel device providing a time efficient platform for evaluating FA images and performing threshold macular laser photocoagulation.

Entities:  

Mesh:

Year:  2012        PMID: 22868445     DOI: 10.1007/s00417-012-2119-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.

Authors:  Masoud Soheilian; Kiumars Heidari Garfami; Alireza Ramezani; Mehdi Yaseri; Gholam A Peyman
Journal:  Retina       Date:  2012-02       Impact factor: 4.256

2.  Semiautomated patterned scanning laser for retinal photocoagulation.

Authors:  Mark S Blumenkranz; Dimitri Yellachich; Dan E Andersen; Michael W Wiltberger; David Mordaunt; George R Marcellino; Daniel Palanker
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

3.  [Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema].

Authors:  M Kernt; R Cheuteu; R G Liegl; F Seidensticker; S Cserhati; C Hirneiss; C Haritoglou; A Kampik; M Ulbig; A S Neubauer
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

4.  Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series.

Authors:  Igor Kozak; Jae Suk Kim; Stephen F Oster; Jay Chhablani; William R Freeman
Journal:  Retina       Date:  2012-05       Impact factor: 4.256

5.  Does laser still have a role in the management of retinal vascular and neovascular diseases?

Authors:  Ankur M Shah; Neil M Bressler; Lee M Jampol
Journal:  Am J Ophthalmol       Date:  2011-07-13       Impact factor: 5.258

6.  Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS.

Authors:  Igor Kozak; Stephen F Oster; Marco A Cortes; Dennis Dowell; Kathrin Hartmann; Jae Suk Kim; William R Freeman
Journal:  Ophthalmology       Date:  2011-01-26       Impact factor: 12.079

7.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

8.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Neil M Bressler; Haijing Qin; Roy W Beck; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

9.  Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.

Authors:  Quan Dong Nguyen; Syed Mahmood Shah; Afsheen A Khwaja; Roomasa Channa; Elham Hatef; Diana V Do; David Boyer; Jeffery S Heier; Prema Abraham; Allen B Thach; Eugene S Lit; Bradley S Foster; Erik Kruger; Pravin Dugel; Thomas Chang; Arup Das; Thomas A Ciulla; John S Pollack; Jennifer I Lim; Dean Eliott; Dean Eliot; Peter A Campochiaro
Journal:  Ophthalmology       Date:  2010-09-19       Impact factor: 12.079

10.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12
View more
  7 in total

1.  [Navigated retinal laser therapy].

Authors:  M Kernt; M Ulbig; A Kampik; A S Neubauer
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

Review 2.  Navigated Laser Therapy for Diabetic Macular Oedema.

Authors:  Marcus Kernt; Michael Ulbig; Anselm Kampik; Aljoscha S Neubauer
Journal:  Eur Endocrinol       Date:  2014-02-28

Review 3.  Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema.

Authors:  Lesley A Everett; Yannis M Paulus
Journal:  Curr Diab Rep       Date:  2021-09-06       Impact factor: 5.430

4.  Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema.

Authors:  Raffael Liegl; Julian Langer; Florian Seidensticker; Lukas Reznicek; Christos Haritoglou; Michael W Ulbig; Aljoscha S Neubauer; Anselm Kampik; Marcus Kernt
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 5.  Modern retinal laser therapy.

Authors:  Igor Kozak; Jeffrey K Luttrull
Journal:  Saudi J Ophthalmol       Date:  2014-09-28

6.  NAVILAS Laser System Focal Laser Treatment for Diabetic Macular Edema - One Year Results of a Case Series.

Authors:  Jesse J Jung; Roberto Gallego-Pinazo1; Antonio Lleó-Pérez; Jonathan I Huz; Irene A Barbazetto
Journal:  Open Ophthalmol J       Date:  2013-09-06

7.  Navigated focal laser photocoagulation for central serous chorioretinopathy.

Authors:  Jay Chhablani; Padmaja Kumari Rani; Annie Mathai; Subhadra Jalali; Igor Kozak
Journal:  Clin Ophthalmol       Date:  2014-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.